Related references
Note: Only part of the references are listed.Conformational rearrangements upon Syk auto-phosphorylation
Ernesto Arias-Palomo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk
Anna Podolanczuk et al.
BLOOD (2009)
A Gene Expression Signature Associated with K-Ras Addiction Reveals Regulators of EMT and Tumor Cell Survival
Anurag Singh et al.
CANCER CELL (2009)
Spleen Tyrosine Kinase Functions as a Tumor Suppressor in Melanoma Cells by Inducing Senescence-like Growth Arrest
Olivier Bailet et al.
CANCER RESEARCH (2009)
Structural Insights for Design of Potent Spleen Tyrosine Kinase Inhibitors from Crystallographic Analysis of Three Inhibitor Complexes
Armando G. Villasenor et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells
S. Gobessi et al.
LEUKEMIA (2009)
Treatment of Rheumatoid Arthritis With a Syk Kinase Inhibitor A Twelve-Week, Randomized, Placebo-Controlled Trial
Michael E. Weinblatt et al.
ARTHRITIS AND RHEUMATISM (2008)
A novel Syk family kinase inhibitor:: Design, synthesis, and structure-activity relationship of 1,2,4-triazolo[4,3-c]pyrimidine and 1,2,4-triazolo[1,5-c]pyrimidine derivatives
Akihito Hirabayashi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK)
Luc J. Farmer et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells
Pablo G. Longo et al.
BLOOD (2008)
Spleen tyrosine kinase: a novel target for therapeutic intervention of rheumatoid arthritis
Malini Bajpai et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Molecular Mechanism of the Syk Activation Switch
Emily Tsang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma
Linfeng Chen et al.
BLOOD (2008)
Steady state kinetics of spleen tyrosine kinase investigated by a real time fluorescence assay
Eva Papp et al.
BIOCHEMISTRY (2007)
3D structure of Syk kinase determined by single-particle electron microscopy
Ernesto Arias-Palomo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2007)
Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor
Polly R. Pine et al.
CLINICAL IMMUNOLOGY (2007)
Structural basis for the inhibition of tyrosine kinase activity of ZAP-70
Sebastian Deindl et al.
CELL (2007)
Spleen tyrosine kinase (Syk), a novel target of curcumin, is required for B lymphoma growth
Murali Gururajan et al.
JOURNAL OF IMMUNOLOGY (2007)
Deregulated Syk inhibits differentiation and induces growth factor-independent proliferation of pre-B cells
Thomas Wossning et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Syk-dependent mTOR activation in follicular lymphoma cells
Ludivine Leseux et al.
BLOOD (2006)
Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptors
Eduard Urich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation
Sylvia Braselmann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Identification of the Syk kinase inhibitor R112 by a human mast cell screen
Alexander B. Rossi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Induction of the interferon response by siRNA is cell type- and duplex length-dependent
Angela Reynolds et al.
RNA (2006)
Cutting edge: Constitutive B cell receptor signaling is critical for basal growth of B lymphoma
Murali Gururajan et al.
JOURNAL OF IMMUNOLOGY (2006)
Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma
B Streubel et al.
LEUKEMIA (2006)
Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma
A Rinaldi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Spleen tyrosine kinase (Syk) as a novel target for allergic asthma and rhinitis
M Ulanova et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
Synthetic studies on novel Syk inhibitors. Part 1: Synthesis and structure-activity relationships of pyrimidine-5-carboxamide derivatives
H Hisamichi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Kinomics: Characterizing the therapeutically validated kinase space
M Vieth et al.
DRUG DISCOVERY TODAY (2005)
Direct comparison of the specificity of gene silencing using antisense oligonucleotides and RNAi
B Bilanges et al.
BIOCHEMICAL JOURNAL (2005)
Src and Syk kinases:: key regulators of phagocytic cell activation
G Berton et al.
TRENDS IN IMMUNOLOGY (2005)
An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment
EO Meltzer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
AD Judge et al.
NATURE BIOTECHNOLOGY (2005)
Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy
DH Kim et al.
NATURE BIOTECHNOLOGY (2005)
Tyrosine kinase inhibitors: a new approach for asthma
WSF Wong et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2004)
A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinase
S Atwell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Antisense strategies
ST Crooke
CURRENT MOLECULAR MEDICINE (2004)
Targeting Syk as a treatment for allergic and and autoimmune disorders
BR Wong et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2004)
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
J Soutschek et al.
NATURE (2004)
Progress in antisense technology
ST Crooke
ANNUAL REVIEW OF MEDICINE (2004)
Potent small molecule inhibitors of spleen tyrosine kinase (Syk)
JYQ Lai et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
The orally available spleen tyrosine kinase inhibitor 2-[7-(3,4-dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]-nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodents
N Yamamoto et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Activation of the interferon system by short-interfering RNAs
CA Sledz et al.
NATURE CELL BIOLOGY (2003)
Discovery and SAR of novel [1,6]naphthyridines as potent inhibitors of Spleen Tyrosine Kinase (SYK)
CL Cywin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Anti-HPA-1a-mediated platelet phagocytosis by monocytes in vitro and its inhibition by Fc gamma receptor (FcγR) reactive reagents
E Wiener et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2003)
Crystal structure and NMR studies of the apo SH2 domains of ZAP-70: Two bikes rather than a tandem
RHA Folmer et al.
BIOCHEMISTRY (2002)
Gene silencing in mammals by small interfering RNAs
MT McManus et al.
NATURE REVIEWS GENETICS (2002)
Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways
DS Schwarz et al.
MOLECULAR CELL (2002)
The druggable genome
AL Hopkins et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Inhibition of allergic inflammation in the airways using aerosolized antisense to Syk kinase
GR Stenton et al.
JOURNAL OF IMMUNOLOGY (2002)
Evaluating the specificity of antisense oligonucleotide conjugates - A DNA array analysis
AA Fisher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells
PJ Paddison et al.
GENES & DEVELOPMENT (2002)
Flow cytometric monocyte phagocytic assay for predicting platelet transfusion outcome
JY Lim et al.
TRANSFUSION (2002)
Piceatannol is an effective inhibitor of IgE-mediated secretion from human basophils but is neither selective for this receptor nor acts on syk kinase at concentrations where mediator release inhibition occurs
K Miura et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2001)
Antisense DNAs as multisite genomic modulators identified by DNA microarray
YS Cho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Structure and function of Syk protein-tyrosine kinase
K Sada et al.
JOURNAL OF BIOCHEMISTRY (2001)
Proximal protein tyrosine kinases it immunoreceptor signaling
S Latour et al.
CURRENT OPINION IN IMMUNOLOGY (2001)
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
SM Elbashir et al.
NATURE (2001)
Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12)
Y Kuno et al.
BLOOD (2001)
RNA interference is mediated by 21-and 22-nucleotide RNAs
SM Elbashir et al.
GENES & DEVELOPMENT (2001)
Aerosolized Syk antisense suppresses Syk expression, mediator release from macrophages, and pulmonary inflammation
GR Stenton et al.
JOURNAL OF IMMUNOLOGY (2000)
LAT is essential for FcεRI-mediated mast cell activation
S Saitoh et al.
IMMUNITY (2000)
RNAi: Double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals
PD Zamore et al.
CELL (2000)
Specific interference with gene function by double-stranded RNA in early mouse development
F Wianny et al.
NATURE CELL BIOLOGY (2000)
Share Paper
